J. David Rosenberg disclosed a 5.74% stake in EWSB Bancorp, Inc. through a Schedule 13D filing. The filing, accepted on July 1, 2026, follows his June 29 purchase of 20,750 shares at $10 each in a subscription offering. The move signals that Rosenberg could engage with the company as he evaluates s…
WESTPORT, Conn., July 01, 2026 (GLOBE NEWSWIRE) -- Compass Diversified NYSE:CODI (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that its Board of Directors (the “Board”) has declared a quarterly cash distribution for each of its three preferred share series…
The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' NASDAQ:VRTX gene therapy in children as young as two with inherited blood disorders, including sickle cell disease, the first such treatment cleared for this age group.Casgevy, a one-time treatment made from a pa…
WASHINGTON (dpa-AFX) - The U.S. Food and Drug Administration (FDA) has authorized Philip Morris International to market its Zyn nicotine pouches as a lower-risk alternative to cigarettes, marking a significant milestone for the fast-growing smokeless nicotine category.The FDA said 20 Zyn nicotine p…
FAIR LAWN, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Columbia Financial, Inc. NASDAQ:CLBK, a Delaware corporation and the mid-tier holding company for Columbia Bank (the “Holding Company”), announced today that at its Annual Meeting of Stockholders held on June 25, 2026, its stockholders approved the…
Q3 results met expectations with 1% revenue growth and 14% higher adjusted EBITDA, despite revised revenue guidance due to timing shifts and international headwinds. Strong deferred revenue and contracted services support confidence in fiscal 2027 growth.Based on Franklin Covey Company [FC] Q3 2026…
Net product sales are projected to reach $660–680M in 2026, driven by strong growth in rare liver and genetic disease medicines. Multiple late-stage pipeline assets, including LIVMARLI, Volixibat, Brelovitug, and Zilurgisertib, are advancing toward regulatory milestones, with five potential approva…
Q3 saw improved margins, strong lease fleet growth, and disciplined capital allocation, with 99% lease utilization and $577M in revenue. Guidance for FY26 remains at $2.4–$2.5B revenue and $3–$3.15 EPS, while macro and regulatory uncertainties persist.Based on Greenbrier Companies, Inc. (The) [GBX…
By Doc LouallenCentrus Energy said it signed a $900 million contract with the Energy Department to shift from a demonstration project to large-scale production of high‑assay, low-enriched uranium.The new, fixed-price Haleu enrichment contract calls for Centrus to deploy commercial-scale production…
Major global expansion includes launches in Canada and Singapore, new crypto and perpetual futures products in Europe, and a 5% crypto deposit boost. Innovations feature AI-powered trading, the launch of Robinhood Chain, DeFi-first stock tokens, and a 7% APY DeFi lending product with robust insuran…
By Christine JiMeta's reported interest in monetizing its AI infrastructure is leading investors to question the sustainability of neocloud business modelsMeta holds $35.2 billion in infrastructure contracts with CoreWeave.Artificial-intelligence infrastructure providers like CoreWeave and Nebius G…
SAN DIEGO, July 1, 2026 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Roblox Corporation (NYSE:RBLX) common stock between October 30, 2025 and April 30, 2026, both dates inclusive (the "Class Period"), have until Friday, August 7, 2026 to…
By Doc LouallenCentrus Energy said it signed a $900 million contract with the Energy Department to shift from a demonstration project to large-scale production of high‑assay, low-enriched uranium.The new, fixed-price Haleu enrichment contract calls for Centrus to deploy commercial-scale production…
By Bill AlpertInvestors have waited with varying levels of patience for multi-cancer screening tests to lift off toward a targeted $30 billion to $50 billion in annual volume. Sales this year from the blood tests will be lucky to top $400 million.But things are looking up, as more tests find their…
Shares of Merck & Co. Inc. (MRK) fell over 2% on Wednesday after the company terminated a mid-stage study of its Alzheimer’s drug MK-1167 being developed with Neuphoria Therapeutics (NEUP), citing business reasons.The company is no longer looking for participants for the trial intended to evaluate…
PORTLAND, Ore., July 1, 2026 /PRNewswire/ -- Portland General Electric Company (NYSE:POR) announced today that it will host an analyst conference call and webcast at 11 a.m. ET on Friday, July 31, to review its second quarter 2026 financial results.Portland General Electric plans to release its sec…
By Hannah PedoneA Guggenheim analyst says valuations for the two software stocks are too depressed, even though the AI threat is realGuggenheim analyst John DiFucci upgraded shares of ServiceNow to buy from neutral on Wednesday.Guggenheim analyst John DiFucci has been a firm believer that artificia…
The S&P 500 and Nasdaq ended lower on Wednesday as investors rotated out of technology and chipmaker stocks in favor of more economically-sensitive stocks, while the Dow Jones ended flat.The S&P 500 fell 0.2%, while the Nasdaq 100 eased 1.5% and the Dow Jones Industrial Average ended flat. The Russ…
By Britney NguyenMost of Sandisk's annual revenue could eventually come from its new business model contracts that provide better visibility, BofA saysSandisk's stock fell Wednesday as investors moved out of the broader chip sector.Shares of Sandisk fell Wednesday as investors moved out of the broa…
The second quarter of 2026 will likely be remembered as one of the strongest periods for U.S. equities in recent memory.Despite ongoing concerns surrounding inflation, interest rates, and geopolitical uncertainty, investors continued to pour money into stocks as corporate earnings exceeded expectat…
